Pharmaceuticals, Biotechnology and Life Sciences
The study, which will be conducted in up to 70 healthy individuals, aims to evaluate the tolerability of KarXT compared to xanomeline alone.
Dechra, an international specialist veterinary pharmaceuticals company, has received approval from the U.S. Food and Drug Administration (FDA) for a generic antibiotic.
Redx CFO steps down, the company searches new one
David Evans, Non-executive Chairman, has stepped down from the Board with immediate effect.
Quay Pharma will be formulating the capsules that will be administered in Redx’s trial.
PureTech gets grant for third U.S. patent for methods of treating infectious and allergic diseases
Positive Phase III EXPAND study for Novartis
“Second quarter financial performance was in-line with expectations.” – Olivier Brandicourt, Sanofi CEO
Faron and Abzena in cancer medicine Clevegen manufacture deal
Vernalis has today announced the completion of the CCP-08 pivotal multiple-dose comparative bioavailability study.